ARTICLE | Clinical News
APF530: Preliminary Phase III data
October 6, 2008 7:00 AM UTC
AP Pharma released top-line results from a double-blind, double-dummy, international Phase III trial in 1,395 patients receiving moderately or highly emetic chemotherapy, comparing 5 mg and 10 mg subc...